These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33302840)

  • 1. Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.
    Baou K; Katsi V; Makris T; Tousoulis D
    Curr Hypertens Rev; 2021; 17(3):196-206. PubMed ID: 33302840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
    Wade C; Wells JM
    Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities.
    Corrao S; Brunori G; Lupo U; Perticone F
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28794142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD.
    Ruzieh M; Baugh AD; Al Jebbawi L; Edwards ES; Jia KQ; Dransfield MT; Foy AJ
    Trends Cardiovasc Med; 2023 Jan; 33(1):53-61. PubMed ID: 34856338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
    Karoli NA; Rebrov AP
    Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
    Mtisi TF; Frishman WH
    Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers in COPD: time for reappraisal.
    Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
    Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
    Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
    Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta-blockers in patients with COPD: current perspective.
    Malerba M; Montuschi P; Radaeli A; Pirisi M
    Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.